Evidence map›Paper›PMID 22013044›Full record

ArticleJournal of virology2012

Stimulation of the human RAD51 nucleofilament restricts HIV-1 integration in vitro and in infected cells.

O Cosnefroy, A Tocco, P Lesbats, S Thierry, C Calmels, T Wiktorowicz, S Reigadas, Y Kwon, A De Cian, S Desfarges and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Complex Relationships between HIV-1 Integrase and Its Cellular Partners.International journal of molecular sciences · 2022
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 3 countries.

O CosnefroyLaboratoire MFP, UMR 5234, CNRS-Université Victor Segalen Bordeaux 2, IFR 66 Pathologies Infectieuses et Cancers, Bordeaux, France.
A Tocco
P Lesbats
S Thierry
C Calmels
T Wiktorowicz
S Reigadas
Y Kwon
A De Cian
S Desfarges
P Bonot
J San Filippo
S Litvak
E Le Cam
A Rethwilm
H Fleury
P P Connell
P Sung
O Delelis
M L Andréola
V Parissi
Centre National de la Recherche Scientifique · FRBiotherapy of Genetic Diseases, Inflammatory Disorders and Cancers · FRInstitut Gustave Roussy · FRUniversity of Würzburg · DEYale University · USGeneTrace Systems (United States) · USUniversity of Chicago · US

Funding

RAD51 Inhibitors for Chemotherapy and Radiation TherapyR01CA142642 · NCI · UNIVERSITY OF CHICAGO · PI CONNELL, PHILIP P · 2010 to 2019
$4.8M
Molecular Basis of BRCA2-mediated DNA Repair and Cancer AvoidanceR01ES015252 · NIEHS · YALE UNIVERSITY · PI SUNG, PATRICK · 2007 to 2016
$3.8M
NCI NIH HHS CA142642-02NCI NIH HHS R01 CA142642NIEHS NIH HHS R01 ES015252NIEHS NIH HHS R01ES015252
6 · The paper itself

Abstract

Stable HIV-1 replication requires the DNA repair of the integration locus catalyzed by cellular factors. The human RAD51 (hRAD51) protein plays a major role in homologous recombination (HR) DNA repair and was previously shown to interact with HIV-1 integrase (IN) and inhibit its activity. Here we determined the molecular mechanism of inhibition of IN. Our standard in vitro integration assays performed under various conditions promoting or inhibiting hRAD51 activity demonstrated that the formation of an active hRAD51 nucleofilament is required for optimal inhibition involving an IN-DNA complex dissociation mechanism. Furthermore we show that this inhibition mechanism can be promoted in HIV-1-infected cells by chemical stimulation of the endogenous hRAD51 protein. This hRAD51 stimulation induced both an enhancement of the endogenous DNA repair process and the inhibition of the integration step. Elucidation of this molecular mechanism leading to the restriction of viral proliferation paves the way to a new concept of antiretroviral therapy based on the enhancement of endogenous hRAD51 recombination activity and highlights the functional interaction between HIV-1 IN and hRAD51.

Indexed as

Down-RegulationVirus IntegrationCell LineDNA RepairDNA, Single-StrandedHIV-1HIV InfectionsHIV IntegraseHumansProtein BindingRad51 RecombinaseRecombination, GeneticDNA, Single-StrandedHIV Integrasep31 integrase protein, Human immunodeficiency virus 1RAD51 protein, humanRad51 Recombinase

Identifiers

PMID22013044
PMCPMC3255893
OpenAlexW1995636174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.